EUVIMEDEUVIMED entdecken
Crossref

Sustained Improvement in Interstage Survival and Outcomes Within the National Pediatric Cardiology Quality Improvement Collaborative

Andrew H Van Bergen iD, Pierce Kuhnell, David W Brown iD, Carole M Lannon iD, Nancy A Rudd iD, Jeffrey B Anderson, Katherine E Bates iD

Circulation: Population Health and Outcomes · 02.11.2026

DOI: 10.1161/circoutcomes.125.013073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Population Health and Outcomes, online erschienen am 02.11.2026. Verfasst von Andrew H Van Bergen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Advocate Children's Heart Institute, Advocate Children's Hospital, Oak Lawn, IL (A.H.V.B.). Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Infants with hypoplastic left heart syndrome remain at high risk during the interstage between stage 1 and stage 2 surgical palliations. As a multicenter Learning Health Network, the National Pediatric Cardiology Quality Improvement Collaborate uses collaborative research and improvement to improve hypoplastic left heart syndrome outcomes for infants. We evaluated whether our previously reported improvement in interstage survival from 90.5% to 94.8% was sustained over time. METHODS: Infants enrolled in the National Pediatric Cardiology Quality Improvement Collaborate clinical registry who underwent stage 1 surgical palliation and were discharged home during the interstage period were included. Patient demographics, hypoplastic left heart syndrome anatomic type, and neonatal hospitalization data in phase 1 (2008–2016) and phase 2 (2016–2025) were compared. Statistical process control was used to analyze rates of interstage survival, major adverse event readmissions, and growth failure. RESULTS: A total of 5495 patients (phase 1—2199, phase 2—3296) were enrolled from 77 centers, of which 38.7% were female and 11.2% had a major syndrome. The phase 2 cohort had a higher prevalence of RV-PA conduit (phase 1: 55.2% versus phase 2: 64.3%; P

Schlagwörter

Stichwörter der Autor:innen

digoxinhospitalizationinfantsmorbidityprescriptions

Autor:innen und Institutionen

  • Advocate Children's Heart Institute, Advocate Children's Hospital, Oak Lawn, IL (A.H.V.B.).
  • Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, OH (P.K.).
  • Department of Cardiology, Boston Children's Hospital, MA (D.W.B.).
  • James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital and Senior Quality Advisor, American Board of Pediatrics (C.M.L.).
  • Children's Hospital of Wisconsin, Milwaukee (N.A.R.).
  • Heart Institute, Cincinnati Children's Hospital Medical Center, OH (J.B.A.).

ORCID-Profile: Andrew H Van Bergen, David W Brown, Carole M Lannon, Nancy A Rudd, Katherine E Bates

Zitieren

APA

Van Bergen, A. H., Kuhnell, P., Brown, D. W., Lannon, C. M., Rudd, N. A., Anderson, J. B., & Bates, K. E. (2026). Sustained Improvement in Interstage Survival and Outcomes Within the National Pediatric Cardiology Quality Improvement Collaborative. Circulation: Population Health and Outcomes. https://doi.org/10.1161/circoutcomes.125.013073

Vancouver

Van Bergen AH, Kuhnell P, Brown DW, Lannon CM, Rudd NA, Anderson JB, et al. Sustained Improvement in Interstage Survival and Outcomes Within the National Pediatric Cardiology Quality Improvement Collaborative. Circulation: Population Health and Outcomes. 2026. doi:10.1161/circoutcomes.125.013073

BibTeX
@article{VanBergen2026,
  author = {Van Bergen, Andrew H and Kuhnell, Pierce and Brown, David W and Lannon, Carole M and Rudd, Nancy A and Anderson, Jeffrey B and Bates, Katherine E},
  title = {Sustained Improvement in Interstage Survival and Outcomes Within the National Pediatric Cardiology Quality Improvement Collaborative},
  journal = {Circulation: Population Health and Outcomes},
  year = {2026},
  doi = {10.1161/circoutcomes.125.013073}
}
Kostenlos starten →